Latest Breaking News On - Marc engelhardt - Page 5 : comparemela.com

Basilea reports new data for ceftobiprole (Zevtera®) presented at US IDWeek Congress 2023

Basilea reports new data for ceftobiprole (Zevtera®) presented at US IDWeek Congress 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalBasel stadtNorth libertyFowler jrMarc engelhardtNils schrInfectious diseases society of americaInstitute for clinical pharmacodynamicsHuman servicesAdministration for strategic preparednessUs idweek congressUs department of healthDuke clinical research instituteInternational journal of antimicrobial agentsSwiss exchange

Basilea announces FDA acceptance of New Drug Application for antibiotic ceftobiprole

02.10.2023 - Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP)Prescription Drug User Fee Act (PDUFA) goal date set for April 03, 2024 Ad . Seite 1

Marc engelhardtBasilea pharmaceutica ltdDrug administrationNew drug applicationPrescription drug user fee actChief medical officerQualified infectious disease productAntibiotics incentives nowBasilea pharmaceutica chartAsilea pharmaceutica kursAsilea pharmaceutica aktie

IV Antibiotic Ceftobiprole Under Review for Serious Bacterial Infections

The FDA has accepted the New Drug Application for ceftobiprole, a broad spectrum cephalosporin antibiotic for IV administration.

Marc engelhardtDrug administrationNew drug applicationChief medical officerPrescription drug user fee act

Antibiotic shows efficacy against complicated Staph bacteremia

Antibiotic shows efficacy against complicated Staph bacteremia
umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.

United statesThomas hollandMarc engelhardtBasilea pharmaceuticaDrug administrationDuke university school of medicineDepartment of medicineDuke universityUs department of healthHuman servicesNew england journalDuke university schoolNew drug application

Basilea announces New England Journal of Medicine publication of phase 3 data on ceftobiprole for the treatment of Staphylococcus aureus bacteremia

Basilea announces New England Journal of Medicine publication of phase 3 data on ceftobiprole for the treatment of Staphylococcus aureus bacteremia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Basel stadtSwitzerland generalVanceg fowler jrThomas hollandNils schrMarc engelhardtDevelopment authorityAdministration for strategic preparednessHead of corporate communications investor relationsBasilea pharmaceutica international ltdBiomedical advanced researchDrug administrationMedicine at duke university school ofUs department of healthHuman servicesSwiss exchange